Using multiple HGSOC cell lines authenticated by genomic profiling [39] and in-house HGSOC patient tumor tissues, we addressed ERβ2-p53 crosstalk and its functional implications in tumor progression and therapeutic resistance. This evidence concerns the gene TP53 and neoplasm.